EFV
Eva Fortea Verdejo
#486 out of 1697 analysts
Wells Fargo
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
14.81%
Gain +0.53%
Monthly
0.51%
Yearly
6.3%
Drawdown
72.11%
$114,811.77
Equity
Holdings
$114,811.77
Cash
$0
Investment
$106,987.75
$14,811.77
Profit +$609.69
Realized
$6,987.75
Unrealized
$7,824.02
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.53%
Profit
$609.69
Win %
80%
This Week
Compared To Last Week
Gain
4.5%
Profit
$4,942.65
Win %
80%
This Month
Compared to last month
Gain
4.5%
Profit
$4,942.65
Win %
80%
This Year
Compared to last year
Gain
46.72%
Profit
$36,559.75
Win %
69%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 121 | Longs Won 82/119 68% | Profit Factor 1.17 |
| Profitability | Shorts Won 1/2 50% | Standard Deviation $5,620.45 |
| Average Win $1,247.93 | Best Trade (Aug 11) $25,348.61 | Sharpe Ratio -68.3 |
| Average Loss -$2,335.97 | Worst Trade (Jun 08) -$38,247.52 | Z-Score -2.47 (100%) |
| Commissions $0 | Avg. Trade Length 1m 4w | Expectancy $122.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 13.56% | 24.75% | 35.18% | 45.16% | 54.8% | 64.2% | 73.38% | 82.4% | 91.26% |
| Consecutive Losing Trades | 49 | 44 | 39 | 34 | 29 | 25 | 20 | 15 | 10 | 5 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 CELC Celcuity Inc. | 307.74 | $31,803.01 | $28,588.61 | - | -$3,214.4 | -10.11% | -0.022% |
 KNSA Kiniksa Pharmaceuticals International, plc | 373.66 | $19,842.94 | $28,588.61 | - | $8,745.67 | 44.07% | -2.011% |
 NUVL Nuvalent, Inc. | 230.63 | $26,053.62 | $28,588.61 | - | $2,534.99 | 9.73% | 0.0 |
 ZYME Zymeworks Inc. | 1,236 | $29,288.18 | $29,045.93 | - | -$242.25 | -0.83% | 0.0 |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
